DeepScribe vs Marvix AI (2026)
Both are built for specialty visits that run longer and carry more history than a short primary care appointment, and they specialize differently. DeepScribe centers on oncology, where it says it is used across 90 percent of community oncology centers, runs inside Epic, Flatiron's OncoEMR and iKnowMed, and has outside evidence in a 98.8 KLAS Spotlight score and a 2025 Journal of Clinical Pathways study on diagnosis capture. Marvix spreads across a claimed 135 or more specialties and subspecialties, with pre charting that pulls prior notes, labs, imaging and medications before the visit, named two way integrations with athenahealth, Veradigm, AdvancedMD, eClinicalWorks, ModMed, DrChrono and NextGen, and E/M levels and codes shown with the medical decision making rationale behind them. If your failure mode is oncology documentation with references a committee will accept, start with DeepScribe. If it is a multi specialty group on one of Marvix's named record systems, start with Marvix, whose 30 day trial includes the live integration.
- Oncology is the center of the product, with integrations into Flatiron's OncoEMR and iKnowMed, a Flatiron partnership covering more than 4,200 providers, and SmartPrep for oncology pre visit preparation.
- The evidence comes from outside the company: KLAS scored DeepScribe 98.8 in its 2025 Spotlight report, built from customer feedback, and an August 2025 study in the Journal of Clinical Pathways reported 16 percent more diagnoses captured per visit and a 21 percent increase in ICD-10 specificity in oncology.
- The paperwork is public. The full business associate agreement is published with the terms of use, and the trust center lists SOC 2 Type II with a report covering 2024 and a bridge letter through 2025.
- Specialty range is the design center, with a claimed 135 or more specialties and subspecialties and named depth in neurology, oncology, orthopedics and nephrology.
- Coding comes with its reasoning, as E/M levels, ICD-10 codes, modifiers and add on codes arrive with the medical decision making rationale that produced them.
- A 30 day trial includes full features and the live two way EHR integration, so a practice can test pre charting and coding on its own patients before buying.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepScribe and Marvix AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DeepScribe | Marvix AI |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2017 | 2023 |
| Headquarters | San Francisco, California | Boston, Massachusetts |
| Website | deepscribe.ai | marvix.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
DeepScribe sells ambient AI documentation built for specialty care, with oncology at its center, to health systems, oncology networks and specialty groups. The scribe listens to the visit, pulls prior notes, labs, imaging, medications and diagnoses forward from the chart, and writes a structured note with coding suggestions back into the EHR.
Source: AI Health Index, August 2026
Marvix AI is a Boston-based clinical documentation platform built for specialty care rather than the short general outpatient visit most scribes assume, targeting long consults, complex histories and longitudinal care across neurology, oncology, orthopedics, nephrology, psychiatry and pediatrics, with a claimed 135 or more specialties and subspecialties.
Source: AI Health Index, August 2026
Questions buyers ask
How do DeepScribe and Marvix AI handle patient data?
The business associate agreement governs protected health information, and DeepScribe describes encryption in transit and at rest, role based access, multifactor authentication and de identification of patient data, with a HIPAA audit report listed in its trust center.
With Marvix AI, the vendor states its de identification process is designed to meet the Safe Harbor standard at 45 CFR 164.514(b)(2), including removal of direct identifiers and measures against re identification from the retained dataset. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Which settings and specialties do DeepScribe and Marvix AI cover?
In DeepScribe's case, the company says it is used across 90 percent of community oncology centers, partners with Flatiron's network of more than 4,200 providers, integrates with OncoEMR and iKnowMed, and sells SmartPrep as an oncology pre visit product. It also publishes pages for cardiology, gastroenterology, neurology, orthopedics and urology, and a partnership with Pearl Health takes it to value based care providers.
For Marvix AI, output extends to after visit summaries, referral letters and patient instructions. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
What evidence is published for DeepScribe and Marvix AI?
KLAS gave DeepScribe a score of 98.8 in its 2025 Spotlight report, built from customer feedback, with 15 A+ marks across culture, loyalty, operations, product, relationship and value.
In Marvix AI's case, the vendor publishes specialty depth and product detail rather than outcomes, and the 30-day trial including full features and integration is a commercial term rather than evidence. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How much do DeepScribe and Marvix AI leave to the clinician?
For DeepScribe, notes arrive in the EHR, whether Epic, OncoEMR or another integrated record, for the clinician to review and sign off, and coding suggestions arrive with them. Capture is fully ambient, with no dictation or wake words, so review at signing is the one point where a person checks the output.
The privacy policy states that outputs are drafts, that they are designed to require review, validation and affirmative acceptance by a licensed healthcare professional before clinical, billing or disclosure use, and that Marvix does not automate the signing, locking or finalization of clinical notes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
DeepScribe's privacy policy keeps personal data for as long as its purpose requires, which may extend past the end of the relationship, and sets no period for encounter audio or transcripts. Marvix publishes no study, accuracy benchmark, third party rating, named customer or deployment count, and no rate card. Both sell coding suggestions alongside the note, and neither publishes how often a suggested code survives audit.
An earlier version of this comparison said DeepScribe's security page claims certifications without naming one; its trust center, opened in July 2025, lists SOC 2 Type II. That statement was corrected on 10 October 2026.